Suppr超能文献

在中心静脉闭塞的血液透析患者中使用聚四氟乙烯(PTFE)移植物进行右锁骨下动脉至右心房旁路移植术:病例报告

Right subclavian artery to right atrium bypass using Polytetrafluoroethylene (PTFE) graft in hemodialysis patient with central venous occlusion: Case report.

作者信息

Rezziki Abdellah, El Malki Hicham, Boukabous Sara, Banana Youssef, Meftah Hicham, Haddiya Intissar, Bentata Yassamine, Moutaouekkil El Mehdi, Benzirar Adnane, El Mahi Omar

机构信息

Department of Vascular Surgery, Mohammed VI University Hospital of Oujda, Mohammed First University of Oujda, Morocco.

Laboratory of Epidemiology, Clinical Research and Public Health, Faculty of Medicine and Pharmacy, Mohammed the First University of Oujda, Morocco.

出版信息

Ann Med Surg (Lond). 2022 Mar 3;76:103438. doi: 10.1016/j.amsu.2022.103438. eCollection 2022 Apr.

Abstract

INTRODUCTION

Central venous Occlusion (CVO) is a serious complication that occurs mainly in patients with long term central venous catheters for dialysis. It remains a challenge in vascular surgery.

CASE PRESENTATION

We report a case of a patient with end-stage kidney disease (ESKD), who was admitted for chronic occlusion of the superior and inferior vena cava and underwent a right subclavian artery to right atrium (RA) bypass using polytetrafuloroetylene (PTFE) graft.

CLINICAL DISCUSSION

Central venous catheters remains the main cause of CVO in ESKD. Although the endovascular therapy is the main approach in the treatment of CVO, the surgical bypass to the RA is often the last resort to preserve vascular access in hemodialysis patients. The autologous vein and bovine arterial bypass remains better than PTFE grafts in terms of long term patency.

CONCLUSION

fistulas as a first approach for dialysis access must be privileged at the expense of central catheters. However bypass to RA by mini thoracotomy incision remains as an excellent option for dialysis access in ESKD with CVO.

摘要

引言

中心静脉闭塞(CVO)是一种严重并发症,主要发生于长期使用中心静脉导管进行透析的患者。它仍是血管外科领域的一项挑战。

病例报告

我们报告一例终末期肾病(ESKD)患者,因上、下腔静脉慢性闭塞入院,接受了使用聚四氟乙烯(PTFE)移植物进行的右锁骨下动脉至右心房(RA)旁路移植术。

临床讨论

中心静脉导管仍是ESKD患者发生CVO的主要原因。虽然血管内治疗是CVO的主要治疗方法,但对RA进行外科旁路移植术往往是维持血液透析患者血管通路的最后手段。就长期通畅性而言,自体静脉和牛动脉旁路移植术优于PTFE移植物。

结论

作为透析通路的首选方法,应优先选择造瘘,减少中心静脉导管的使用。然而,对于伴有CVO的ESKD患者,经小切口开胸进行RA旁路移植术仍是透析通路的一个极佳选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d47/8960889/409acdb3442f/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验